Business Details
33 Years
experience
Global Leader in Brand Naming & Identity Development
Emmaus Institute is the global leader in brand name and identity development with over 30 years of experience serving clients across industries. Founded in 1993, we specialize in creating impactful brand names, conducting trademark research, and delivering regulatory expertise through our wholly-owned subsidiary, Drug Safety Institute. Our team of seasoned professionals combines creative innovation with rigorous compliance to ensure brand names meet global regulatory standards while resonating with target audiences.With offices in major cities worldwide, we provide localized service backed by deep industry knowledge. Our commitment to excellence has earned trust from 1500+ companies, including major pharmaceutical, healthcare, and consumer goods firms. We pride ourselves on exceeding client expectations through strategic insights, proven methodologies, and a client-centric approach that prioritizes timing and budgetary requirements.
Services
Name Development
Trademark Searches
Market Research
Regulatory Services
Visual Identity
Details
- Year established: 1993
Highlights and features
- We have over 30 years of experience in brand naming and identity development
- Our team has developed 6000+ brand names with 75%+ approval rate for Rx names
- We maintain a 96% Health Canada approval success rate for name submissions
- Our Drug Safety Institute subsidiary employs former FDA and EMA naming officials
- We offer 24/7 client support with offices in 15+ global locations
What people say
Great job providing strategic perspective
Successful INN submission achievement
Consumer embraced new brand identity
Services
Name Development
Our expert namers create distinctive brand identities using proprietary methodologies and linguistic analysis. We develop names that resonate with target audiences while meeting regulatory requirements across 30+ therapeutic categories. Clients benefit from our 30-year track record of 6000+ successful name creations with high regulatory approval rates.
Trademark Searches
Our in-house legal team conducts comprehensive global trademark analyses to identify potential conflicts. We provide risk assessments and clearance opinions covering 150+ jurisdictions, ensuring brand names achieve maximum legal protection while minimizing infringement risks during commercialization.
Regulatory Services
Through Drug Safety Institute, we offer regulatory strategy development and submission support for pharmaceutical names. Our former FDA and EMA officials provide expert guidance on name safety research, labeling requirements, and approval strategies across major global markets.
Market Research
We conduct quantitative and qualitative research to evaluate name performance across key metrics. Our global panel provides benchmarked data on name recognition, memorability, and market appeal across 20+ therapeutic areas and consumer product categories.
Visual Identity
Our award-winning designers create cohesive visual systems that extend brand identity across all touchpoints. Services include logo development, packaging design, and marketing collateral creation that aligns with brand strategy and regulatory requirements for healthcare products.
People
James L. Dettore
Founder, Chairman & CEO
Founder of Emmaus Institute with 50 years of brand management experience. Created industry-defining naming protocols and established Drug Safety Institute. Inducted into Phi Lambda Sigma Pharmacy Leadership Society for contributions to patient safety.
William Johnson
Co-Chief Executive Officer
24-year veteran leading 2000+ branding projects. Oversees global operations and strategic direction. Former Market Research Manager turned executive leader with expertise in pharmaceutical and consumer healthcare branding.
Jerry Phillips
President, Regulatory Strategy
Former FDA official with 16 years regulatory experience. Created FDA's proprietary name testing methodology. Leads Drug Safety Institute's regulatory consulting services for pharmaceutical name safety and compliance.
Scott Piergrossi
President, Creative
19-year veteran leading creative naming initiatives. Developed thousands of brand names across healthcare and consumer sectors. Expert in trademark law and regulatory affairs integration with creative development.
Sophia Fuerst
President, Nonproprietary Division
Former Director of USAN Program at American Medical Association. 18 years nomenclature expertise. Oversees nonproprietary name development and regulatory strategy for pharmaceutical standardization.
Questions
What services does Brand Institute offer?
We provide brand name development, trademark research, regulatory strategy, market research, and visual identity design for pharmaceutical, healthcare, and consumer product companies globally.
How experienced is Brand Institute in pharmaceutical naming?
With 30+ years experience, we've developed 6000+ brand names and maintain 75%+ approval rates for Rx names across major global regulatory agencies.
Can you help with regulatory name approvals?
Our Drug Safety Institute subsidiary employs former FDA, EMA, and Health Canada officials who provide expert guidance for regulatory name submissions and compliance.
What is your naming process timeline?
Project timelines vary by complexity but typically range from 4-8 weeks, including creative development, trademark screening, and regulatory evaluation phases.
Do you work with international clients?
Yes, we serve clients globally through 15+ offices across North America, Europe, Asia, and Latin America with localized language and regulatory expertise.
What industries do you specialize in?
While serving diverse sectors, we specialize in pharmaceuticals, biotechnology, medical devices, consumer healthcare, and branded consumer products.
